1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
61AD672DE93A1BEA385256DBB00657527
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/in-licensing-organization-structure?opendocument
18
19
20
21
22
23
24/bestp/domrep.nsf
25DB




Products & Services New Product Development New Product Development: Structure and Functions

In-Licensing Organization Structure

DB Image

ID: 4498


Features:

Metrics, Graphics


Words: 5,479


Published: Pre-2013


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
This 19-page document examines key elements that determine the structure of high-performing in-licensing operations. A dozen best practices and multiple narratives from business development executives at leading pharmaceutical companies detail the most effective ways to marshal personnel resources, develop effective and efficient organizational and reporting lines, and measure success of their in-licensing operations. This document originated in a Best Practices, LLC consulting project.

Industries Profiled:
Pharmaceutical; Biotech; Chemical; Health Care; Medical Device


Companies Profiled:
AstraZeneca; Sanofi-aventis; Bristol-Myers Squibb; GlaxoSmithKline; Genentech; Johnson & Johnson; Novartis; Roche


If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.